Clinical Trial Update: Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED) [Phase 4]

View source ↗

Summary

A Phase 4 placebo-controlled trial of Nasonex for nasal obstruction due to adenoids hypertrophy in children has been terminated/withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoidectomy
• Adenoids Hypertrophy
• Nasal Obstruction

Drugs mentioned

• Nasonex (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Nasal Obstruction, Adenoids Hypertrophy | Phase 4 | Status: WITHDRAWN